INCY Presents VGA039 Data
INCY Star Therapeutics is presenting complete data from a Phase 1/2 multidose study of VGA039 in Von Willebrand Disease at the ISTH 2026 Congress
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
INCY Star Therapeutics is presenting complete data from a Phase 1/2 multidose study of VGA039 in Von Willebrand Disease at the ISTH 2026 Congress